COMMUNIQUÉS West-GlobeNewswire

Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1
13/02/2018
BOSTON, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP ), today announced that management will host a conference call and webcast slide presentation on Thursday, March 1, at 4:30 p.m. ET to [...]
Shire Provides Regulatory Progress Update for Key Pipeline Programs Targeting Rare Disease
13/02/2018
Shire Provides Regulatory Progress Update for Key Pipeline Programs Targeting Rare Disease - U.S. FDA Grants Orphan Drug Designation for Investigational SHP647 for Treatment of Pediatric Patients with Moderately to [...]
RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018
13/02/2018
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
CampDoc.com Partners with CCC to Offer Integrated Camp Electronic Health Record Solution
13/02/2018
ANN ARBOR, Mich., Feb. 13, 2018 (GLOBE NEWSWIRE) -- CampDoc.com, the leading electronic health record system for camps , has partnered with CCC, a provider of fully integrated software solutions for member-centric [...]
Natus to Present at Raymond James 39th Annual Institutional Investors Conference
13/02/2018
PLEASANTON, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jonathan Kennedy, Executive Vice-President and Chief Financial Officer will present at the Raymond [...]
Amunix CEO to deliver keynote address on ProTIA, Amunix’s novel immuno-oncology technology, at the Biologics & Biosimilars Congress Europe (March 2018)
13/02/2018
MOUNTAIN VIEW, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. (Amunix), a biopharmaceutical company focused on the discovery and development of novel immuno-oncology therapeutics, announced today that [...]
Initiation of stock buyback program
13/02/2018
Please read the full announcement in the attached PDF http://prlibrary-eu.nasdaq.com/Resource/Download/c28caac0-5533-4304-8726-857202a7a695
Avivagen to Seek Approval from TSX Venture Exchange for Extension of Warrants
13/02/2018
OTTAWA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]
Invitation to Novozymes' annual shareholders' meeting 2018
13/02/2018
Please see attached for further details http://prlibrary-eu.nasdaq.com/Resource/Download/9277d98c-4398-4d3f-9b11-2ba43f3518da http://prlibrary-eu.nasdaq.com/Resource/Download/72dd8aea-22b4-483d-9b4e-9c66000bafdb
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
13/02/2018
FIT Biotech Oy Company release February 13, 2018 at 1:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Digirad Corporation to Release 2017 Fourth Quarter and Year-End Financial Results on February 23, 2018
13/02/2018
SUWANEE, Ga., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD ) will release financial results for its fourth quarter and year ended December 31, 2017, before the market opens on Friday, February 23 [...]
CV Sciences, Inc. to Present and Exhibit as Silver Sponsor at Natural Products Expo West 2018 in Anaheim, California, March 7-11, 2018
13/02/2018
LAS VEGAS, Feb. 13, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that its industry dominating [...]
Sanofi : Information concerning the total number of voting rights and shares
13/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/1cb41595-1a62-4ba3-8cef-ecfd855d267e
Sanofi : Informations relatives au nombre total de droits de vote et d'actions
13/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/92a363dc-7bd0-4339-a43f-78bc215823f3
Cytovance® Biologics, Inc. announces completion of first batch in new state-of-the-art 1000L microbial facility
13/02/2018
OKLAHOMA CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, announces completion of first batch in [...]
Trading by management and of close relations to management
13/02/2018
Please see attached for details of the transaction http://prlibrary-eu.nasdaq.com/Resource/Download/79c8b9e6-f1b0-45d0-827b-e8b1dcb5773f
Transactions in relation to share buyback program
13/02/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Affimed Announces Pricing of Public Offering of Common Stock
13/02/2018
Heidelberg, Germany February 13, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced the pricing [...]
Olainfarm to Strengthen Belarus Operations
13/02/2018
Olaine, 2018-02-13 09:00 CET (GLOBE NEWSWIRE) -- “Since acquisition of daughter companies we are putting a lot of effort to integrate them and use as many synergies as we can. In NPK Biotest, we have created a certified [...]

Pages